Met Life Investment Management, LLC Cue Biopharma, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$3.11 - $4.91 $57,566 - $90,884	18,510 New	18,510 $67,000
Q2 2023 Aug 10, 2023	BUY	$3.11 - $4.91 $57,566 - $90,884	18,510 New	18,510 $67,000
Q1 2022 May 12, 2022	SELL	$4.41 - $12.28 $52,095 - $145,063	-11,813 Closed	0 $0
Q4 2021 May 17, 2024	BUY	$10.86 - $17.85 $59,360 - $97,568	5,466 Added 86.12%	11,813 $133,000
Q4 2021 Jun 21, 2023	BUY	$10.86 - $17.85 $128,289 - $210,862	11,813 New	11,813 $133,000
Q4 2021 Mar 22, 2023	BUY	$10.86 - $17.85 $59,360 - $97,568	5,466 Added 86.12%	11,813 $133,000
Q4 2021 Feb 15, 2022	BUY	$10.86 - $17.85 $59,360 - $97,568	5,466 Added 86.12%	11,813 $134,000
Q3 2021 May 17, 2024	SELL	$10.06 - $15.3 $66,033 - $100,429	-6,564 Reduced 50.84%	6,347 $92,000
Q3 2021 Jun 21, 2023	BUY	$10.06 - $15.3 $63,850 - $97,109	6,347 New	6,347 $92,000
Q3 2021 Mar 22, 2023	SELL	$10.06 - $15.3 $66,033 - $100,429	-6,564 Reduced 50.84%	6,347 $92,000
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $66,033 - $100,429	-6,564 Reduced 50.84%	6,347 $92,000
Q2 2021 Jun 21, 2023	BUY	$10.9 - $14.53 $140,729 - $187,596	12,911 New	12,911 $150,000
Q1 2021 May 17, 2024	BUY	$11.2 - $16.09 $144,603 - $207,737	12,911 New	12,911 $157,000
Q1 2021 Jun 26, 2023	BUY	$11.2 - $16.09 $144,603 - $207,737	12,911 New	12,911 $158 Million
Q1 2021 Mar 22, 2023	BUY	$11.2 - $16.09 $985 - $1,415	88 Added 0.69%	12,911 $157,000
Q1 2021 May 14, 2021	BUY	$11.2 - $16.09 $985 - $1,415	88 Added 0.69%	12,911 $158,000
Q4 2020 Jun 22, 2023	BUY	$11.12 - $16.4 $142,591 - $210,297	12,823 New	12,823 $160,000
Q3 2020 Jun 26, 2023	BUY	$15.05 - $23.54 $192,986 - $301,853	12,823 New	12,823 $192,000
Q2 2020 May 24, 2024	BUY	$12.7 - $30.73 $162,852 - $394,050	12,823 New	12,823 $314 Million
Q2 2020 Jun 26, 2023	BUY	$12.7 - $30.73 $162,852 - $394,050	12,823 New	12,823 $314,000
Q2 2020 Mar 22, 2023	BUY	$12.7 - $30.73 $35,775 - $86,566	2,817 Added 28.15%	12,823 $314,000
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $35,775 - $86,566	2,817 Added 28.15%	12,823 $314,000
Q1 2020 Jul 12, 2023	BUY	$9.85 - $22.27 $98,559 - $222,833	10,006 New	10,006 $141,000
Q4 2019 Jul 12, 2023	BUY	$7.06 - $17.47 $70,642 - $174,804	10,006 New	10,006 $158,000
Q4 2019 Mar 22, 2023	BUY	$7.06 - $17.47 $70,642 - $174,804	10,006 New	10,006 $158,000
Q4 2019 Feb 14, 2020	BUY	$7.06 - $17.47 $70,642 - $174,804	10,006 New	10,006 $159,000

Others Institutions Holding CUE

# of Institutions

Shares Held

14.1M

Call Options Held

14.4K

Put Options Held

2.6K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account